Terms & Conditions, Licensing agreement & bilateral confidentiality agreement

Content license summary

You are granted the right to

• Use content from Longevity School in your private personal use, in accordance with the attached licensing agreement

• Note that multiple licenses are required for non-family members

• The Lifetime Membership term for the Pre-orders offer is 50 years with the annual membership fee waived and a discounted purchase price

You are not granted the right to

• Share content with other people outside of your family without prior permission, in accordance with the attached licensing agreement

• Share specific additional content that is distributed to you in confidence and highlighted to be ‘confidential’, in accordance with the attached licensing agreement and bilateral confidential disclosure agreement

Attribution summary

Attribution to Oliver Zolman is required for the following content when it is used to ensure the maintenance of intellectual property rights

• By use of a watermark where present

• By use of name for biomarkers or biological age markers with ‘Zolman’ in the name; these should retain the Zolman name in the marker due to it reflecting intellectual property of Oliver Zolman and the use of a specific methodology (for example, Z-BAM (Zolman Biological Age Marker) criteria compliance)

• Mention of the Longevity Level 1, 2, 3 protocol as ‘Dr Zolman’s Longevity Level 1, 2, 3 protocol’

Attribution Examples

• Watermarked Materials: If written permission is granted, when presenting data or protocols obtained from Longevity School, include a visible watermark such as '© Dr Zolman & 20ONE Consulting Limited' or 'Licensed Content - Longevity School' on all electronic materials (e.g., slides, reports, or documents). The watermark should occupy at least 10% of the document space.

• Citing Protocols: For protocols like 'Longevity Level 1, 2, 3' or others provided by Longevity School, include an acknowledgment in text such as 'Based on the Longevity Level 1 Protocol by Dr Zolman & 20ONE Consulting Limited' in the introduction or methods section.’

• Biomarker Attribution: When using biomarker names such as 'Zolman Biological Age Marker (Z-BAM),' ensure that the full name is retained and accompanied by a reference like 'Developed by Dr Oliver Zolman, 20ONE Consulting Limited.'

• Presentations and Public Use: When presenting at conferences or publishing related findings, include a footnote or slide that states: 'Content derived from licensed materials of Longevity School, © Dr Zolman & 20ONE Consulting Limited.'

• Shared Data: In publications or shared clinical results, attribution must read: 'This data was generated using methods licensed from Longevity School, developed by Dr Zolman & 20ONE Consulting Limited.

Sharing your Individual/Family Rejuvenation Results Encouragement

Through becoming a Longevity School member, you are encouraged to

• Measure rejuvenation/health biomarkers

• Share your rejuvenation/health results and methodologies used with us, other longevity school clinicians, journals and the public, as to benefit the wider medical community and pool clinical data (these data could meet confidentiality and anonymisation requirements such as the UK ICO’s anonymisation Code of Practice however it is up to your personally)

Disclaimer

The content provided through Longevity School, including presentations and discussions by doctors and clinicians, is for informational and educational purposes only. It is not intended to constitute medical advice or replace consultation with a qualified healthcare provider. Always seek the advice of your physician or another qualified healthcare professional regarding any medical condition or treatment. The use of any information provided is solely at your own risk.

Returns and Cancellation Policy

Cancellation Before Access
You may cancel your order and request a full refund within 14 days of purchase, provided you have not accessed or viewed more than 2 hours of the course content.

Cancellation After Partial Access
If you have accessed less than 2 hours of the course content, you are still eligible for a refund within the 14-day cancellation period. Once you have accessed or viewed more than 2 hours of the content, refunds will no longer be provided.

Defective Content
If you encounter issues with the course content (e.g., inaccessible or corrupted materials), we will offer a replacement or work to resolve the issue without additional charge.

Pre-order and Delivery Estimate
By placing a pre-order, you acknowledge that you are purchasing content that is only partially yet available. The estimated delivery date for access to each new module is 1 new module per month after 1st. March 2025. While we aim to meet these dates, unforeseen delays may occur. In the event of a delay, we will notify you promptly with a revised timeline.

Pre-orders may be cancelled and refunded in full at any time before access to the course content is granted.

Consultations Disclaimer

Consultations with Dr. Zolman or other representatives of Longevity School do not constitute medical advice. All consultations are for informational and educational purposes only and should not be interpreted as medical consultation or care. These consultations are subject to the Nature of 20ONE Consulting Ltd’s B2B & B2C Services Policy, outlined below:

Nature of 20ONE Consulting Ltd’s B2B & B2C Services Policy
What 20ONE Consulting Ltd Does Not Provide
20ONE Consulting Ltd does not provide:

Medical advice
Prescription therapies
Prescription tests
Diagnoses, treatment, prevention, or cure of any disease, disorder, or injury
Prescriptions
Triage
Emergency care
A doctor-patient relationship
Prognoses
These services are available through our partner organisations.

What 20ONE Consulting Ltd Does Provide
20ONE Consulting Ltd offers the following services to B2B and B2C clients:

Educational information
Medical information and services relevant to clients’ medical data
Medical information management, collation, storage, and analysis
Literature and commercial search and analysis
Clinician or specialist search and analysis
Administration services
Data analysis
Biostatistical analysis
Marketing services

Licensing Agreement

An AGREEMENT dated as per the foot of this document or otherwise of the first payment date and made between
(1) 20one Consulting Ltd, 128 City Road, London City Road, London, England, EC1V 2NX (“Licensor”); and

(2) The Client as signed at the bottom of this document ("Client") or checked on a Terms & Conditions checkbox at checkout on a sales page;

together the "Parties"

1 DEFINITIONS
Supplied Data means the data provided by the Licensor to the Client and includes any adaptations of that data to the extent any intellectual property rights in those adaptations belong or are licensed to the Licensor, such as videos, documents or audio files, or the web or mobile apps from the online course.
Commercial Purposes means any purposes which are undertaken with the intention of making a Financial Gain, regardless of whether a Financial Gain is actually made.

Confidential Information means all information or data provided to the Client by or on behalf of the Licensor or by a third party with the authority of the Licensor in connection with this Licence, in any form or medium, whether before or after the date of this Licence and whether relating to the past, present or future, (including without limitation information of a commercial, marketing, financial, technical, operational or other nature, intentions, ideas, plans, proposals, results, investigations, research, surveys, operations, processes, reports, statistics, know-how, trade secrets, software including source code, intellectual property rights including any part and any derivative of such information and the existence and terms of this Licence and any documents referred to in this Licence and the commercial and financial arrangements evidenced by this Licence and any documents referred to in this Licence).

Core Business Means any health sector activity.
Financial Gain means a net gain (after the deduction of costs related to generating the revenue or credit referred to below) from the receipt by the Licensor, Client or a third party of any revenue or credit for the use, publication or display of any Supplied Data other than payment received by the Client in relation to the Project from the Licensor. Financial Gain does not include any receipts of statutory charges.
Project means the specific project (including evaluation and tendering) or series of projects assigned to the Client by the Licensor in relation to which this Licence is required, if no specific project or series of projects are stated it is presumed the project is use of the content for enhancing patient outcomes via healthcare services

Term means the duration of the Project

Territory means globally

Use means copying, using and/or amending whether in electronic or paper form and Using shall have an equivalent meaning

2 LICENCE
2.1 In consideration of the mutual covenants and obligations in this Licence and any related Project documents together with the payment by the Client of the sum determined between the Parties of which once has been received by the Licensor, the Licensor now grants to the Client a non-exclusive, non-transferable licence to Use Supplied Data for the Project in the Territory for the Term.
2.2 This Licence is limited specifically to the rights granted above and subject to the obligations set out in the remainder of this Licence, in particular the Client's obligations set out in clause 3. This Licence allows the Client personally (not any affiliated body or group) to use Supplied Data only to the extent required for the Project.
2.3 Scope of License:
• The license is granted solely for the specific project(s) outlined in this agreement and for no other purpose.
• Usage of the licensed content beyond the project(s) requires prior written approval from the Licensor.
2.4 Termination of License:
• The Licensor may terminate this license under the following circumstances:
o Material Breach: If the Client violates any terms of this agreement and fails to remedy the breach within 7 days of receiving written notice.
o Misuse of Data: If the Client uses the Supplied Data outside the agreed scope or for unauthorized purposes.
o Mutual Agreement: If both parties agree to terminate the license in writing.
2.5 Consequences of Termination:
• Upon termination, the Client must:
o Cease all use of the Supplied Data.
o Return or destroy all copies of the Supplied Data, including adaptations or modifications, and certify such destruction in writing to the Licensor within 14 days.
• Any ongoing projects relying on the Supplied Data must also be discontinued.
2.6 Renewal or Extension:
• The license is valid for the duration of the project. Extensions or renewals must be agreed upon in writing before the license’s expiration.
2.7 Audit Rights:
• The Licensor reserves the right to audit the Client’s use of the Supplied Data to ensure compliance with the terms of this agreement. The Client must cooperate fully with any such audit.
2.8 Multiple Licenses:
• Any non-family member requires a separate license unless otherwise agreed in writing by the Licensor.
3 CLIENT'S OBLIGATIONS
3.1 The Client shall Use the Supplied Data exclusively for the Project and for no other purpose.
3.2 The Client shall ensure that:
(a) any copy protection measures are not altered;
(b) appropriate watermarks (as outlined in the introduction) and acknowledgements are included on the data and on any paper copies produced in order to render the Supplied Data unsuitable for any other purpose;
(c) the Supplied Data is used only for the purpose of the Project;
(d) the Supplied Data is not copied, adapted, varied or modified except to the extent and only to the extent to which any of those acts are expressly permitted by this Licence;
3.3 The Client shall ensure that the trade marks contained in the Supplied Data or any other Licensor materials supplied with, or in addition to, the Supplied Data are not altered, obscured, removed or added to and the Client shall only use the trade marks in the manner indicated by Licensor from time to time.
3.4 The Client shall take all reasonable steps to prevent unauthorised use and exploitation of Supplied Data by any person, including, without limitation, its employees.
3.5 The Client shall notify the Licensor as soon as reasonably practicable should it become aware of any unauthorised use of the Supplied Data. The Client shall, at the cost and expense of the Client, provide all reasonable assistance to the Licensor in the pursuit of any remedy in relation to any such unauthorised use or breach of licence and the Licensor shall have absolute discretion with regards to what action to take.
3.6 The Client hereby assigns to the Licensor all present and future intellectual property rights it owns in amendments or adaptations made to the Supplied Data or other original works produced in performing the Project and irrevocably waives its moral rights.
4 ENTIRE AGREEMENT
4.1 This Licence, including its Schedules and all documents which are required by its terms to be entered into by the Parties, sets out the entire agreement between the Parties in connection with the subject matter of this Licence and supersedes all prior oral or written agreements, arrangements or understandings between them.
4.2 The Parties acknowledge that they have not entered into this Licence in reliance upon any warranty, representation, covenant, undertaking, agreement, term or condition which is not set out in this Licence.
4.3 Without prejudice to clauses 4.1 and 4.2 above, the Parties irrevocably and unconditionally waive any right they may have to claim damages and/or to rescind this Licence for any misrepresentation whether innocent or negligent whether in tort, under the Misrepresentation Act 1967 or otherwise or for any breach of any warranty not contained in this Licence unless such misrepresentation or warranty was made or given fraudulently.
5 ASSIGNMENT AND SUBLICENSING
5.1 Neither Party may assign any of its rights or the benefit of all or part of this Licence without the prior written consent of the other party.
5.2 The Client may not sub-license any of its rights or the benefit of all or part of this Licence without the prior written consent of the Licensor.
6 CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 1999
6.1 For the purpose of section 1(2) of the Contracts (Rights of the Third Parties) Act 1999 the Parties state that they do not intend any term of this Licence to be enforced by any third parties.
7 INDEMNITY
7.1 The Client shall indemnify and keep indemnified the Licensor against all their liabilities and losses and all demands, liabilities, claims made, or proceedings brought, against the Licensor in respect of any loss or damage and against all costs and expenses reasonably incurred in dealing with or in settling such demands, liabilities, claims or proceedings arising from:
(a) the acts, omissions or defaults of the Client relating to this Licence; and
(b) the breach of any provision of this Licence by the Client;
except to the extent that any such liability is directly attributable to any negligent act of the Licensor.
7.2 The Licensor shall notify the Client as soon as practicable and in any event within 10 working days of any demand or claim made, or proceedings brought against the Licensor in respect of any relevant loss or damage.
8 JURISDICTION AND GOVERNING LAW
8.1 Subject to clause 9, the validity, construction and performance of this Licence shall be governed by English law and the parties submit to the exclusive jurisdiction of the English Courts.
9. DISPUTE RESOLUTION PROCEDURE
9.1 Nothing in this procedure relieves either party of obligations under this Licence or restricts the Licensor's ability to commence court proceedings where urgent action is required.
9.2 Senior representatives must meet within 15 working days of referral to resolve the Matter. Any resolution must be recorded in writing and will bind both parties.
9.3 If unresolved, mediation or early neutral evaluation must begin within 30 working days, with procedures agreed by both parties.
9.4 If mediation fails within 60 working days, the Matter will be referred to binding arbitration under the rules of the chosen Arbitration Institution. The arbitration will be conducted by a single arbitrator agreed by both parties or, if no agreement is reached, appointed by the Institution. The decision will be final and binding.
9.5 Costs of mediation or arbitration will be shared equally unless agreed otherwise. The venue will be London, England, unless both parties agree on an alternative.
9.6 Nothing in this clause restricts either party’s right to seek interim or injunctive relief in a court of law where urgent action is required.
10. CONFIDENTIALITY
10.1 The Client shall not disclose this Licence or any provision of it or any Confidential Information obtained in connection with, or during the course of, this Licence, to any person unless it is strictly necessary for the performance of this Licence or Core Business. This Clause does not apply in relation to Confidential Information:
(a) which is in or enters the public domain otherwise than by a breach of an obligation of confidentiality;
(b) which is or becomes known from other sources without breach of any restriction on disclosure; or
(c) which is required to be disclosed by law or any professional or regulatory obligation.
10.2 Subject to Clause 10.1, the Client shall ensure that Confidential Information about this Licence, or arising from or connected with this Licence:
(d) is divulged only to the minimum number of persons;
(e) is divulged only to the extent essential to each person's action in carrying out (or in connection with) this Licence and that such persons do not further divulge such Confidential Information; and
(f) is properly safeguarded.
10.3 The Client shall not, in connection with this Licence, communicate with representatives of the general or technical press, radio, television or other communications media unless specifically granted permission in writing to do so by the Licensor.
10.4 No Confidential Information regarding the provision of the data under this Licence or facilities to photograph or film shall be given or permitted by the Client to any person except with prior written permission of the Licensor. This Clause 10.4 does not apply in relation to Confidential Information:
(g) which is in or enters the public domain otherwise than by a breach of an obligation of confidentiality;
(h) which is or becomes known from other sources without breach of any restriction on disclosure; or
(i) which is required to be disclosed by law or any professional or regulatory obligation including the Parties' obligations to report to Parliament or any other government body.
10.5 Except with the consent in writing of the Licensor, the Client shall not make use of this Licence or any Confidential Information issued or furnished by or on behalf of the Licensor otherwise than for the purposes of this Licence.
10.6 The Client shall take all reasonable steps to ensure the observance of the provisions of this Clause 10 inclusive about by all its employees, office holders, workers and sub-Clients.
11 Non-Solicitation
11.1 The Client agrees not to directly or indirectly solicit, hire, or influence any employee, consultant, or contractor of the Licensor to terminate or alter their relationship with the Licensor. This obligation applies during the term of this Licence and for a period of 12 months following its termination.
11.2 This restriction does not apply to hiring resulting from general recruitment efforts, including public job advertisements or recruitment agency searches, provided they are not specifically targeted at the Licensor’s staff.
11.3 In the event of a breach of this clause, the Client shall compensate the Licensor for any resulting financial losses, including but not limited to recruitment, training, and onboarding costs for replacement staff.
12 DATA PROTECTION
12.1 Data will be handled according to GDPR regulations in accordance with the privacy policy at www.oliverzolman.com/?open=privacy-policy
13 WEBSITE AND APP TERMS AND CONDITIONS
13.1 The website and app content and services will be subject to the same terms and conditions as the www.oliverzolman.com website found at https://www.oliverzolman.com/?open=terms-and-conditions
Earnings disclaimer
We make no guarantees about your earnings or success from using Longevity School products. Any examples of earnings or outcomes are provided as illustrations only and are no promises of what you will achieve. Your results will depend on various factors, including your background, experience, dedication, and effort.
Please be aware that:
Past results do not guarantee future success.
Economic and market conditions may impact your outcomes.
Success requires effort, skill, and the ability to apply the knowledge effectively.
We encourage you to seek advice from qualified professionals, such as financial or legal advisors, before making decisions based on our materials. Use of our content is entirely at your own risk.
Modifications to terms
We reserve the right to update or modify these Terms and Conditions at any time with material changes being communicated to users via email (if provided) or through a prominent notice on our website. Continued use of our services after such updates constitutes acceptance of the revised terms. It is your responsibility to review the Terms and Conditions periodically for any updates.
 
Bilateral Confidential Disclosure Agreement

We understand that the Subject Party and its affiliates (collectively, “Company”) may be interested in pursuing a confidential relationship and or transaction with 20ONE Consulting Limited, of 128 City Road, London City Road, London, England, EC1V 2NX and its affiliates including Zolman Clinics Ltd, all of the same address, (collectively, “20ONE Consulting”) on a mutually agreeable basis. 20ONE Consulting and Company (each a “Disclosing Party”), for their mutual benefit, are each desirous of disclosing to the other (each a “Receiving Party”) certain product, financial, marketing, manufacturing, organizational, technical and other information related to the Disclosing Party and its business, including certain Proprietary Information and Intellectual Property (as hereinafter defined) (herein collectively referred to as the “Confidential Information”) for the purpose of considering a mutually beneficial business combination. Confidential Information includes not only written information but also information transferred orally, visually, electronically or by any other means.
For purposes of this letter Agreement, “Proprietary Information” means any trade or business secrets of the Disclosing Party and any scientific, technical or business materials that are treated by the Disclosing Party as confidential or proprietary, including but not limited to any software products, information to which the Receiving Party and/or its authorized representatives and agents may have access relating to the Disclosing Party's present or planned business which could include the names and addresses of the Disclosing Party's customers or prospective customers and methods of doing business and certain other business information which the Disclosing Party has furnished to the Receiving Party and/or its authorized representatives and agents, as well as information concerning techniques, processes and programs relating to the Disclosing Party's customers and the Disclosing Party's products and any companies with which the Disclosing Party does business; sales processes and procedures; costs; the Disclosing Party's general business procedures and operations, financial information, invoices, accounts receivable, billings, reports, correspondence and payment of billings; sales information and/or information concerning profits; merchandising, sales or marketing strategies and techniques; expansion plans with respect to marketing, products or otherwise; methods of servicing customers; methods of pricing or charging for services and products; business forms developed by or for the Disclosing Party; with respect to the Disclosing Party, form and content of proposals, reports and analyses; names of suppliers, personnel or employees; advertising sources and potential advertising sources; internal reporting methods; bids; contracts; proposals; scientific and technical data, specifications and other documentation, whether written, oral or machine-readable; forecasts; predictions; designs; formulae; software programs, however embodied; information about or belonging to customers, potential customers or others and any other information relating to the operation, business, customers and sources of supply for all or any of the Disclosing Party’s products.
For purposes of this letter Agreement, “Intellectual Property” means any writing, drawing, logo, computer program, manual, trade name, trademark, service mark or other material of the Disclosing Party registered or otherwise protected or protectable under any patent, trademark, copyright or similar laws.
In consideration of the Disclosing Party furnishing the Receiving Party with the Confidential Information, and as a condition to such disclosure, 20ONE Consulting and Company mutually agree as follows:

1. The Confidential Information will be used by the Receiving Party solely for the purposes of providing business, scientific or clinical advice to benefit 20ONE Consulting and of its evaluation of the desirability of its entering into a transaction with the Disclosing Party, concerning the Disclosing Party as a whole, and for no other purposes.

2. The Receiving Party shall keep all Confidential Information secret and confidential and shall not disclose it to anyone without the written consent of the directors of 20ONE Consulting Limited. Each person to whom such Confidential Information is disclosed must be advised of its confidential nature and of the terms of this Agreement and (unless already bound by obligations of confidentiality) must agree to abide by such terms. The fact that such information has been delivered to the Receiving Party, that such a transaction is under consideration by the Receiving Party, and that discussions or negotiations have occurred or are occurring regarding a possible transaction are considered Confidential Information for purposes of this Agreement.

3. Each party agrees that it will not, without the prior written consent of the other, issue any press release or announcement or otherwise disclose the existence or nature of this Agreement and/or any proposed business arrangement.

4. Without the Disclosing Party’s prior approval, the Receiving Party agrees not to contact any employee of the Disclosing Party concerning the Receiving Party’s potential interest in advice or a transaction with the Disclosing Party.

5. Upon any termination of an advisory role and or its evaluation of pursuing a transaction with the Disclosing Party or upon notice from the Disclosing Party to it, the Receiving Party will either destroy or return to the Disclosing Party the Confidential Information which is in tangible form, including any copies which it may have made, and the Receiving Party will destroy all abstracts, summaries thereof or references thereto in its documents, and certify to the Disclosing Party that it has done so. In addition, neither the Receiving Party nor its directors, employees, agents, or representatives will at any time use any of the Confidential Information with respect to, or in furtherance of, its business, any of their respective businesses, or in the business of anyone else, whether or not in competition with the Disclosing Party, or for any other purpose whatsoever.

6. Confidential Information does not include any information, which the Receiving Party can show was

a. known to it prior to receipt of such information or

b. publicly available prior to its receipt of such information or thereafter became publicly available by legal means.

Information shall be deemed “publicly available” if it becomes a matter of public knowledge or is contained in materials available to the public or is obtained from any source other than the Disclosing Party (or its directors, officers, employees or outside advisors), provided that such source has not to the Receiving Party’s knowledge entered into a confidentiality agreement with the Disclosing Party with respect to such information or obtained the information from an entity or person party to a confidentiality agreement with the Disclosing Party or such information to the Receiving Party’s knowledge was not otherwise improperly obtained from the Disclosing Party or improperly disseminated by the source.

7. The Receiving Party understands that the Disclosing Party has endeavoured to include in the Confidential Information those materials which it believes to be reliable and relevant for the purpose of the Receiving Party’s evaluation, but the Receiving Party acknowledges that neither the Disclosing Party nor any of its agents, representatives, or employees makes any representation or warranty as to the accuracy or completeness of the Confidential Information and the Receiving Party agrees that such persons shall have no liability to it or any of its representatives resulting from any use of the Confidential Information. In addition, the Receiving Party understands that the Confidential Information is not intended to satisfy the requirements of any applicable securities laws relating to the offer or sale of securities to the Receiving Party.

8. The Receiving Party acknowledges and agrees that any and all financial projections and business plans received from the Disclosing Party were prepared by the Disclosing Party's management solely for planning and for informational and discussion purposes among the Disclosing Party's board of directors and other professional advisors, and that such financial projections and/or business plans reflect management's judgment as of a particular point in time. In addition, the Receiving Party acknowledges and agrees that there may be differences between the results forecasted in the financial projections and business plans received from the Disclosing Party and actual results because events and circumstances frequently do not occur as expected and that those differences may be material.

9. In the event that the Receiving Party (or anyone to whom it transmits the Confidential Information pursuant to this Agreement) becomes legally compelled to disclose any of the Confidential Information, the Receiving Party will provide the Disclosing Party with prompt notice so that the Disclosing Party may seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement, the Receiving Party (or anyone to whom it transmits the Confidential Information pursuant to this Agreement) will furnish only that portion of the Confidential Information which it is advised by a written opinion of counsel is legally required and it will cooperate with the Disclosing Party in any actions that the Disclosing Party may take to obtain a protective order or other reliable assurance that confidential treatment will be accorded the Confidential Information.

10. The Receiving Party understands and agrees that this Agreement is made for the mutual benefit of the 20ONE Consulting and Company, and no failure or delay by the Disclosing Party or its agents or representatives in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege under this Agreement. The Receiving Party further agrees that money damages would not be a sufficient remedy for any breach of this Agreement by it, or its employees, directors or representatives, and that the Disclosing Party, its agents and representatives shall be entitled to specific performance and/or injunctive relief as a remedy for any such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity.

11. The Receiving Party agrees not to solicit to employ or to employ any of the current employees of the Disclosing Party so long as they are employed by the Disclosing Party

a. during the period in which there are discussions conducted pursuant hereto, and

b. for a period of one year after the termination of such discussions.

Nothing contained in this paragraph shall be deemed or construed to limit or impair in any manner the rights or remedies of the Disclosing Party concerning employment of its current and former employees

12. Nothing in this Agreement shall impose any obligation upon the Receiving Party or the Disclosing Party to consummate a transaction or to enter into any discussion or negotiations with respect thereto. Neither this paragraph nor any other provision in this Agreement can be waived or amended except by written consent of the Disclosing Party, which consent shall specifically refer to this paragraph (or such other provision) and explicitly make such waiver or amendment.

13. English law shall govern the construction, validity and performance of this Agreement and the parties hereby submit to the non-exclusive jurisdiction of the English courts.

14. If any provision of this Agreement shall be held invalid in a court of law, the remaining provisions shall be construed as if the invalid provisions were not included in this Agreement.

15. The obligations of confidentiality under this Agreement shall remain indefinitely whilst there is an advisory, transactional or any other business relationship between the Parties, related to 20ONE Consulting Limited or subsequent subsidiaries or spin-off organisations of 20ONE Consulting Limited, collectively known as a '20ONE Consulting and Related Venture Professional Relationship'; abbreviated 'Relationship'. Cessation of the Relationship must be made to 20ONE Consulting explicitly in writing and include the signature of Company and the date of signing. In the case of cessation of the Relationship, the obligations of confidentiality under this Agreement shall terminate three (3) years from the date of cessation of the Relationship.

Use of Trademarks

1. Permitted Use:
o The Client may use the Licensor's trademarks, including logos, names, and proprietary terms (e.g., "Zolman Biological Age Marker" or "Z-BAM"), solely for the purposes outlined in this agreement.
o Trademarks must always be accompanied by proper attribution (e.g., "Trademark of 20ONE Consulting Limited, used under license").
2. Prohibited Use:
o The Client may not modify, adapt, or alter any trademarks.
o Trademarks must not be used in a way that implies endorsement, partnership, or ownership by the Client without explicit written approval from the Licensor.
3. Presentation Standards:
o Trademarks must be used in accordance with branding guidelines provided by the Licensor, including font, colour, and placement.
o Improper presentation (e.g., resizing logos disproportionately or using them in unrelated materials) is prohibited.
4. Withdrawal of Rights:
o The Licensor reserves the right to revoke permission to use trademarks at any time with written notice if use is deemed inappropriate or in violation of this agreement.
5. Acknowledgement:
o All materials using Licensor trademarks must acknowledge the Licensor’s ownership of the trademark (e.g., "© 20ONE Consulting Limited. All rights reserved.").
 
ACCEPTANCE

By signing or purchasing, the Parties indicate their acceptance of the contents of this document and that have capacity to make this decision